Assistant Professor, Hematology and Medical Oncology, Emory University School of Medicine
Hematology
Dr. Ajay K. Nooka, MD
|
|
Give Review
Ajay Nooka is an expert in the field of Hematology. He went to medical school at Andhra Medical College NTR. Ajay Nooka is a published doctor. He has 32 publications published. The most current publication "Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice." Ajay Nooka accepts Medicare.
Publications
- Central nervous system involvement by multiple Myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.
- Cost-effectiveness of lenalidomide plus dexamethasone vs bortezomib plus melphalan and prednisone in transplant-ineligible US patients with newly-diagnosed multiple my...
- Tuberculosis in umbilical cord blood transplant recipients: clinical characteristics and challenges.
- Predictors of survival outcomes in phase 1 relapsed or refractory multiple Myeloma patients.
- Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell Lymphoma.
- Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem Cell transplantation.
- Optimal dosing of melphalan as high-dose therapy before autologous hematopoietic stem Cell transplantation in myeloma patients with solitary kidney: a case series.
- Second primary malignancies with lenalidomide therapy for newly diagnosed Myeloma: a meta-analysis of individual patient data.
- Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin Lymphoma.
- Consolidation and maintenance therapy with lenalidomide, bortezomib, dexamethasone (RVD) in high-risk Myeloma patients.
- Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic Cell transplants from partially mismatched unrelated donors.
- Temporal changes in plerixafor administration and hematopoietic stem Cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma.
- Bortezomib-containing induction regimens in transplant-eligible Myeloma patients: A meta-analysis of phase 3 randomized clinical trials.
- Prognostic Indicators and Treatment Outcome in 94 Cases of Fibrolamellar HepatoCellular Carcinoma.
- Relapsed and refractory lymphoid neoplasms and multiple Myeloma with a focus on carfilzomib.
- Examination of the follicular Lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predomin...
- Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
- Oral capecitabine for the treatment of hepatoCellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.
- From Single Nucleotide Polymorphisms to Constant Immunosuppression: Mesenchymal Stem Cell Therapy for Autoimmune Diseases.
- Racial differences in the presentation and outcomes of chronic lymphocytic Leukemia and variants in the United States.
- Treatment of severe neutropenia with high-dose pyridoxine in a patient with Chronic graft versus host disease and squamous cell carcinoma: a case report.
- Hepatitis C reactivation in patients who have diffuse large B-cell Lymphoma treated with rituximab: a case report and review of literature.
- A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple Myeloma: a dose- and schedule-finding study.
- Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple Myeloma: a retrospective study.
- Improving induction therapy in multiple Myeloma.
- The importance of complete response in outcomes in Myeloma.
- Supportive therapies in multiple Myeloma.
- Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intraVenous bisphosphonates.
- Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence.
- Bilateral adrenal hemorrhage: an overlooked cause of hypotension.
- Thalidomide in the treatment of patients with hepatoCellular carcinoma: a phase II trial.
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Chronic Myeloid Leukemia (CML)
- Coagulation Disorders (incl. Hemophilia)
- View All
Doctors Specialties
- Hematology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Choice HMO
- Blue Choice Option POS
- Blue Open Access POS
- Direct Access w/HSA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Golden Rule
- GEHA
- Choice Care PPO
- Preferred PPO
- Mail Handlers Benefit Plan (MHBP)
- MedHealthInsurance
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Planned Administration Inc
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Wells Fargo Insurance
Education
-
Emory University -
Andhra Medical College NTR
Hospital
-
Emory University Hospital Midtown -
Emory University Hospital -
Grady Memorial Hospital
Drug Facts
| NPI NUMBER | 1801000260 | |
| NPPES Provider LastName | NOOKA | |
| NPPES Provider FirstName | AJAY | |
| NPPES Provider ZIPCode | 303221013 | |
| NPPES Provider State | GA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1159.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 164.0 | |
| Percent Opioid Claims | 14.15 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801000260 |
| Last Name Of The Provider | NOOKA |
| First Name Of The Provider | AJAY |
| View All |
Similar Doctors
|
|
Dr. Sagar Lonial, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Yih-Ming Yang, MD |
|
Dr. Douglas C. Collins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul L. Richter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter A. Lane Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jessica L. Dreger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles B. Hutchinson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Amy Gartner, CPNP |